submit your investigational new drug (ind) application and clinical holds (9/14) redi 2017
Published 4 years ago • 5.8K plays • Length 40:53Download video MP4
Download video MP3
Similar videos
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
3:25
how to register an investigational new drug (ind) to the us fda
-
40:34
demystifying the investigational new drug (ind) application for drugs and biologics (3of14) redi '18
-
33:18
investigational new drug (ind) submission: content/format and first 30 days (5of14) redi 2018
-
1:11
investigational new drug (ind) application
-
37:56
regulatory and administrative components of an ind application (5/14) redi 2017
-
5:30
what is investigational new drug (ind) application? | regulatory learnings | drug regulatory affairs
-
4:59
research investigational new drug applications – what you need to know
-
3:59
step 5: how to submit an investigational new drug (ind) application to usfda? | regulatory learnings
-
1:15:32
webinar about us investigational new drug (ind) applications
-
3:13
step 6: how does usfda review an investigational new drug (ind) application (part 2)? | dra
-
54:28
overview of non-clinical assessment in drug development (8/14) redi 2017
-
2:15
step 6: how does usfda review an investigational new drug (ind) application? | regulatory learnings
-
1:20
investigational new drug (ind) for us fda | phase 1 to 4 clinical trials services | drug development
-
14:37
keynote (1/14) redi 2017
-
18:21
assembling the best team to navigate through preclinical development
-
3:32
webinar key takeaways: avoiding common pitfalls in the ind and cta submission process
-
6:05
fda drug approval process trailer